References
1. Kalbacher D, Schafer U, RS VB, et al. Long-term outcome, survival and
predictors of mortality after MitraClip therapy: Results from the German
Transcatheter Mitral Valve Interventions (TRAMI) registry. Int J
Cardiol. 2019;277:35-41.
2. Lurz P, Stephan von Bardeleben R, Weber M, et al. Transcatheter
Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. J Am
Coll Cardiol. 2021;77(3):229-239.
3. Meggiolaro M, Scatto A, Zorzi A, et al. Confirmation of correct
central venous catheter position in the preoperative setting by
echocardiographic ”bubble-test”. Minerva Anestesiol.2015;81(9):989-1000.
4. E. Z. Ueber den Bau und die Entstehung der endocaridtischen
Efflorescenzen. Ver Kong Inn Med. 1888;7: 339– 343.
5. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic
endocarditis in cancer patients: pathogenesis, diagnosis, and treatment.Oncologist. 2007;12(5):518-523.
6. Deppisch LM, Fayemi AO. Non-bacterial thrombotic endocarditis:
clinicopathologic correlations. Am Heart J. 1976;92(6):723-729.
7. Gonzalez Quintela A, Candela MJ, Vidal C, Roman J, Aramburo P.
Non-bacterial thrombotic endocarditis in cancer patients. Acta
Cardiol. 1991;46(1):1-9.
8. Kuramoto K, Matsushita S, Yamanouchi H. Nonbacterial thrombotic
endocarditis as a cause of cerebral and myocardial infarction. Jpn
Circ J. 1984;48(9):1000-1006.
9. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic
endocarditis: a review. Am Heart J. 1987;113(3):773-784.